Prognostic validity of a Novel American Joint Committee on Cancer staging classification for pancreatic neuroendocrine tumors

Journal of Clinical Oncology

Volumn 29, Issue 22, 2011, Pages 3044-3049

  Strosberg, Jonathan R ^a   Cheema, Asima ^a   Weber, Jill ^a   Han, Gang ^a   Coppola, Domenico ^a   Kvols, Larry K ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER STAGING; CORRELATION COEFFICIENT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENTAL FINDING; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RACE DIFFERENCE; SEX DIFFERENCE; SURVIVAL TIME; ADVISORY COMMITTEE; ANALYSIS OF VARIANCE; CLASSIFICATION; GASTRINOMA; GLUCAGONOMA; INSULINOMA; MIDDLE AGED; MORTALITY; PANCREAS TUMOR; PATHOLOGY; PREDICTIVE VALUE; REPRODUCIBILITY; RETROSPECTIVE STUDY; RISK FACTOR; UNITED STATES; VALIDATION STUDY; VIPOMA;

ADOLESCENT; ADULT; ADVISORY COMMITTEES; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; FEMALE; GASTRINOMA; GLUCAGONOMA; HUMANS; INCIDENTAL FINDINGS; INSULINOMA; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES; VIPOMA;

EID: 80051619926     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.35.1817     Document Type: Article

References (11)

1. Fesinmeyer MD, Austin MA, Li CI, et al: Differences in survival by histologic type of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 14:1766-1773, 2005 (Pubitemid 40995093)
2. Yao JC, Hassan M, Phan A, et al: One hundred years after "carcinoid": Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26:3063-3072, 2008
3. Halfdanarson TR, Rubin J, Farnell MB, et al: Pancreatic endocrine neoplasms: Epidemiology and prognosis of pancreatic endocrine tumors. Endocr Relat Cancer 15:409-427, 2008 (Pubitemid 351880831)
4. Capella C, Heitz PU, Hofler H, et al: Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch 425:547-560, 1995
5. Solcia E, Kloppel G, Sobin LH (eds): Histological Typing of Endocrine Tumors: WHO International Histological Classification of Tumors (ed 2). Berlin, Germany, Springer, 2000
6. Rindi G, Kloppel G, Alhman H, et al: TNM staging of foregut (neuro)endocrine tumors: A consensus proposal including a grading system. Virchows Arch 449:395-401, 2006 (Pubitemid 44451313)
7. Pape UF, Jann H, Muller-Nordhorn J, et al: Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer 113:256-265, 2008
8. Edge SB, Byrd DR, Compton CC, et al (eds): AJCC Cancer Staging Manual (ed 7). Chicago, IL, Springer, 2010
9. Shariff SZ, Cuerden MS, Jain AK, et al: The secret of immortal time bias in epidemiologic studies. J Am Soc Nephrol 19:841-843, 2008
10. Halfdanarson TR, Rabe KG, Rubin J, et al: Pancreatic neuroendocrine tumors (PNETs): Incidence, prognosis and recent trend toward improved survival. Ann Oncol 19:1727-1733, 2008
11. Bilimoria KY, Bentrem DJ, Merkow RP, et al: Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors. J Am Coll Surg 205:558-563, 2007 (Pubitemid 47446316)